Portfolio comparison
Washington University in St. Louis vs Dexcom
Side-by-side portfolio analysis — patents indexed, year ranges, and activity timeline.
Company A
Washington University in St. Louis
Patents indexed
1
Year range
2026
Most recent
2026
biotechpharmaceuticalgene_editingoncology
Top Patents1 enriched
US 12564648· 2026
Gene Editing T-Cells to Fight CD7 Blood Cancers
Activity by Decade
2020s1
Company B
Dexcom
Patents indexed
6
Year range
2016 – 2022
Most recent
2022
softwarebiotechtelecommunicationsconsumer_electronicsmedical_devices
Top Patents6 enriched
US 9282925· 2016
How Glucose Sensors Check Their Own Reliability for Insulin Pumps
US 11432772· 2022
Smartly Fixing Noisy Glucose Sensor Readings
US 10052055· 2018
How an Implanted Sensor Checks Its Own Accuracy Over Time
Activity by Decade
2010s2
2020s2
How to use
Bookmark a comparison URL to save it. Format: /compare/companies?a=[slug]&b=[slug]. Also see patent-level comparison.